Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BEAZER HOMES USA INCBZH · Entity 5036 | Director | November 17, 2025 | November 18, 2025 |
| EQUIFAX INCEFX · Entity 3235 | EVP, Chief Legal Officer | February 11, 2025 | February 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BEAZER HOMES USA INC
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,116 |
Reported balance
After 2025-11-17 transaction · row 1
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 7,199 · Balance 23,116 F1: Restricted stock award scheduled to vest on the first anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award scheduled to vest on the first anniversary of grant date.
EQUIFAX INC
Report date February 11, 2025 · Filed February 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,175 |
Last balance in matching sequence
After 2025-02-11 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-02-11 · Grant · Acquired 2,710 · Balance 17,202 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 2 · 2025-02-11 · Tax withholding · Disposed 2,027 · Balance 15,175 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2017 Filed Feb 23, 2017 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 10,443 | $129.36 | $1,350,906.48 |
DisclosureSEC source: 0001225208-17-004319 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · CVP, CLO & CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,287 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 14,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-004319 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · CVP, CLO & CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,730 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 11:01 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 8,279 | $0.00 Strike: $129.93 | $0.00 |
DisclosureSEC source: 0001225208-17-003811 · doc4.xml · derivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · CVP, CLO & CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,279 Underlying: Common Stock · 8,279 shares Expires 2027-02-16 F2 · derivative.exercise_date: The option vests in three equal annual increments beginning 2/16/2018. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 11:01 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003811 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · CVP, CLO & CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,214 F1 · security: Award of restricted stock units. The stock vests 100% on 2/16/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.